Patients
9.6 %
Early deaths from long-term diseases, Canada, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Canada Leadless Pacemakers Market Industry Trends and Forecast to 2034: Segmented by (Type, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$135.9 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $69.4 Mn | — | — |
| 2025 (base) | $77.6 Mn | +$8.3 Mn | — |
| 2026 (forecast) | $86.9 Mn | +$9.2 Mn | +11.9% |
| 2027 (forecast) | $97.2 Mn | +$10.3 Mn | +25.2% |
| 2028 (forecast) | $108.8 Mn | +$11.6 Mn | +40.1% |
| 2029 (forecast) | $121.7 Mn | +$12.9 Mn | +56.8% |
| 2030 (forecast) | $136.2 Mn | +$14.5 Mn | +75.4% |
| 2031 (forecast) | $152.4 Mn | +$16.2 Mn | +96.3% |
| 2032 (forecast) | $170.6 Mn | +$18.1 Mn | +119.7% |
| 2033 (forecast) | $190.9 Mn | +$20.3 Mn | +145.8% |
| 2034 (forecast) | $213.6 Mn | +$22.7 Mn | +175.1% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $77.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $213.6 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 11.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Type, application and end user (see all) |
| Key players | Medtronic, Abbott Laboratories, Boston Scientific Corporation, MicroPort Scientific Corporation, Biotronik SE & Co. KG (see all) |
| Regulator in Canada | Health CanadaSource: Health Canada. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Leadless pacemakers are tiny pacemakers placed directly inside the heart through a vein, with no wires under the skin.
Key segments of the leadless Pacemakers market include type (Single-Chamber and Dual-Chamber) and application (Bradycardia and AV Block).
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the leadless Pacemakers market.
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the leadless Pacemakers market room to grow.
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the leadless Pacemakers market.
The leadless Pacemakers market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Health Canada licenses Class II, III and IV medical devices; Class I devices are sold by companies that hold an establishment licence.[1] Each province and territory runs public health insurance under the Canada Health Act, which covers medically necessary hospital and doctor services.[2] Early deaths from long-term diseases: 9.6% in 2023, the latest WHO figure for Canada.[3]
[1] Health Canada. Checked 14 Nov 2026.
[2] Health Canada. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 15 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how leadless Pacemakers products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Canada.
What doctors and scientists are doing in Leadless Pacemakers right now, from free public sources.
9.6 %
Early deaths from long-term diseases, Canada, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Early deaths from long-term diseases (WHO) (%). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 15 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.
From our blog
Canada
Canada
Canada
Canada
Canada
Canada
Digital Health · Canada
Pharmaceuticals · Canada
Pharmaceuticals · Canada
Pharmaceuticals · Canada
Pharmaceuticals · Canada
Healthcare Services · Canada